Top Markets
#1 DogBull DogBull +108.33%
#2 ADO Protocol ADO Protocol +52.43%
#3 MarsCoin MarsCoin +49.06%
#4 Siacoin Siacoin +44.45%
#5 Nockchain Nockchain +22.09%
#6 Ontology Gas Ontology Gas +20.89%
#7 Apertum Apertum +19.60%
#8 Useless Coin Useless Coin +18.44%
#9 Falcon Finance Falcon Finance +17.38%
#10 UnifAI Network UnifAI Network +16.23%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Classifica tra le azioni #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Prezzo delle azioni
$9.42
Capitalizzazione di mercato
$354.69M
Variazione (1 giorno)
-0.83%
Variazione (1 anno)
91.09%
Paese
US
Scambia BioAge Labs Inc. (BIOA)

Categoria

Healthcare
Storico del prezzo dell'azione per BioAge Labs Inc. (BIOA)
Prezzo di chiusura più alto: $9.59 il 2026-09-01

Prezzo di chiusura più basso: $20.04 il 2024-09-01
Storico del prezzo dell'azione di BioAge Labs Inc. dal 2024 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.99 40.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 45.51%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.15 502.53%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $747.56 4.77%
CH